ransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, today announced that the FDA has granted Orphan Drug Designation for the non-radiolabeled version of its anti-cancer compound TM601.
Category Archive for 'Trials'
The addition of capecitabine to lapatinib in patients with brain metastases from breast cancer was associated with additional responses in the central nervous system, researchers reported here at the 30th Annual San Antonio Breast Cancer Symposium (SABCS).
Scientists have tailored a virus to target and destroy brain tumor stem cells that are unresponsive to other cancer therapies, according to a report in the Sept. 18 edition of the Journal of the National Cancer Institute…
A stunning new and highly experimental treatment for the most deadly type of brain tumor helped save the life of a 52-year-old man.
A common human virus may prove useful in attacking the deadliest form of brain tumors, according to study conducted by researchers at Duke’s Preston Robert Tisch Brain Tumor Center.
The cancer drug Avastin — an established but expensive treatment for lung, breast and colon cancers — may also be a powerful weapon against the most deadly type of brain tumor.
Colon and lung cancer drug Avastin, along with standard chemotherapy, increases survival rates of patients with a very deadly type of brain tumor, U.S. researchers said on Thursday…
Within minutes after being stung by the scorpion known as the deathstalker (Leiurus quinquestriatus), weakness starts to kick in. The feeling quickly spreads, paralyzing its prey (typically insects) for hours – just enough time for the scorpion to enjoy dinner…
The Brain Tumor Research Center at the University of California, San Francisco has initiated a Phase 2 clinical trial of an investigational vaccine for treating glioma, a recurrent cancer of the central nervous system that occurs primarily in the brain…
